Aytu BioPharma Inc (AYTU): Next-Year EPS Estimate 92.45%
As of 2026-06-11, Aytu BioPharma Inc (AYTU) has a next-year EPS growth estimate of 92.45%.
On 2026-06-11, analyst consensus for AYTU's next-year EPS growth shifted from 93.95% to 92.45% — a negative change of 1.50 percentage points. Current-year growth is projected at 53.10%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 92.45%
- EPS growth this year
- 53.10%
- EPS next quarter (est)
- -$0.29
- Last price
- $2.19
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 92.45% | 53.10% | -$0.29 | $2.19 |
| 2026-06-10 | 93.95% | 53.69% | -$0.28 | $2.24 |
| 2026-06-09 | 93.95% | 53.69% | -$0.28 | $2.30 |
| 2026-06-08 | 93.95% | 53.69% | -$0.28 | $2.29 |
| 2026-06-07 | 93.95% | 53.69% | -$0.28 | $2.25 |
| 2026-06-04 | 93.95% | 53.69% | -$0.28 | $2.12 |
| 2026-06-03 | 93.95% | 53.69% | -$0.28 | $2.09 |
| 2026-06-02 | 93.95% | 53.69% | -$0.28 | $2.10 |
| 2026-06-01 | 93.95% | 53.69% | -$0.28 | $2.15 |
| 2026-05-31 | 93.95% | 53.69% | -$0.28 | $2.29 |
| 2026-05-28 | 93.95% | 53.69% | -$0.28 | $2.24 |
| 2026-05-27 | 93.95% | 53.69% | -$0.28 | $2.21 |
| 2026-05-26 | 93.95% | 53.69% | -$0.28 | $2.18 |
| 2026-05-25 | 93.95% | 53.69% | -$0.28 | $2.19 |
| 2026-05-24 | 93.95% | 53.69% | -$0.28 | $2.19 |
| 2026-05-21 | 93.95% | 53.69% | -$0.28 | $2.13 |
| 2026-05-20 | 93.95% | 53.69% | -$0.28 | $2.15 |
| 2026-05-19 | 93.95% | 53.69% | -$0.28 | $2.08 |
| 2026-05-18 | 93.95% | 53.69% | -$0.28 | $2.10 |
| 2026-05-17 | 93.95% | 53.69% | -$0.28 | $2.19 |
| 2026-05-14 | 67.44% | 48.82% | -$0.34 | $2.27 |
| 2026-05-13 | 68.52% | 47.05% | -$0.44 | $2.24 |
| 2026-05-12 | 68.52% | 47.05% | -$0.44 | $2.30 |
| 2026-05-11 | 68.52% | 47.05% | -$0.44 | $2.44 |
| 2026-05-10 | 68.52% | 47.05% | -$0.44 | $2.50 |
| 2026-05-07 | 68.52% | 47.05% | -$0.44 | $2.47 |
| 2026-05-06 | 68.52% | 47.05% | -$0.44 | $2.56 |
| 2026-05-05 | 68.52% | 47.05% | -$0.44 | $2.57 |
| 2026-05-04 | 68.52% | 47.05% | -$0.44 | $2.55 |
| 2026-05-03 | 68.52% | 47.05% | -$0.44 | $2.61 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Aytu BioPharma Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Aytu BioPharma Inc (AYTU) has a next-year EPS growth estimate of 92.45%, based on analyst consensus.
When was the latest EPS estimate revision for AYTU?▾
The most recent revision occurred on 2026-06-11, when analysts adjusted the next-year EPS growth estimate from 93.95% to 92.45%.
What sector and industry does Aytu BioPharma Inc belong to?▾
Aytu BioPharma Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AYTU appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aytu BioPharma Inc (AYTU) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports